Abuse of U.S. generic-drug rules costs consumers billions, report says

WASHINGTON, July 23 (Reuters) - U.S. rules, aimed at ensuring prescription medicines are not misused, have been manipulated by brand-name drug companies to keep cheaper competition off the market, costing consumers billions of dollars, a report said on Wednesday.